Literature DB >> 2316621

Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.

H P Friedl1, D J Smith, G O Till, P D Thomson, D S Louis, P A Ward.   

Abstract

We evaluated effluent blood from extremities of human patients undergoing reconstructive surgical treatment, which is routinely accompanied by upper-extremity exsanguination and application of a tourniquet, resulting in total interruption of arterial blood flow to one upper extremity. After tourniquet release (reperfusion), there were immediate increases in the plasma levels of xanthine oxidase activity, uric acid, and histamine in the ipsilateral limb and much smaller increases, if any, in levels of the same materials in plasma obtained from the contralateral extremity. There was no detectable xanthine dehydrogenase activity in plasma from either limb. Plasma also contained evidence of products consistent with the formation of oxygen-derived free radicals, namely, the appearance predominantly in the reperfused limb of hemoglobin and fluorescent compounds. These data indicate for the first time in humans that ischemia-reperfusion events are associated with the appearance of xanthine oxidase activity and its products in the plasma effluent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316621      PMCID: PMC1877490     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O).

Authors:  W R Waud; K V Rajagopalan
Journal:  Arch Biochem Biophys       Date:  1976-02       Impact factor: 4.013

2.  Thermal injury, intravascular hemolysis, and toxic oxygen products.

Authors:  J R Hatherill; G O Till; L H Bruner; P A Ward
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

Authors:  J C Fantone; P A Ward
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

4.  Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma.

Authors:  W F Petrone; D K English; K Wong; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

5.  Xanthine oxidase and neutrophil infiltration in intestinal ischemia.

Authors:  M B Grisham; L A Hernandez; D N Granger
Journal:  Am J Physiol       Date:  1986-10

6.  Generation of an activated form of human C5 (C5b-like C5) by oxygen radicals.

Authors:  W V von Zabern; D Hesse; R Nolte; Y Haller
Journal:  Immunol Lett       Date:  1987-02       Impact factor: 3.685

7.  Significance of xanthine oxidase in capillary endothelial cells.

Authors:  E D Jarasch; G Bruder; H W Heid
Journal:  Acta Physiol Scand Suppl       Date:  1986

8.  Neutrophil-mediated methemoglobin formation in the erythrocyte. The role of superoxide and hydrogen peroxide.

Authors:  S J Weiss
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

9.  Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.

Authors:  J L Romson; B G Hook; S L Kunkel; G D Abrams; M A Schork; B R Lucchesi
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Systemic complement activation, lung injury, and products of lipid peroxidation.

Authors:  P A Ward; G O Till; J R Hatherill; T M Annesley; R G Kunkel
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  18 in total

1.  Priming effects of leukotriene B4 on endothelial cell injury induced by TPA-activated leukocytes.

Authors:  N Suda; I Morita; T Kuroda; S Murota
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

2.  Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

Authors:  S D Anker; F Leyva; P A Poole-Wilson; W J Kox; J C Stevenson; A J Coats
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 3.  Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.

Authors:  Shampa Chatterjee; Gary F Nieman; Jason D Christie; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-19       Impact factor: 5.464

4.  Mesenteric artery clamping/unclamping-induced acute lung injury is attenuated by N-methyl-D-aspartate antagonist dextromethorphan.

Authors:  R Ben-Abraham; M Guttman; R Flaishon; N Marouani; D Niv; Avi A Weinbroum
Journal:  Lung       Date:  2006-11-10       Impact factor: 2.584

Review 5.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20

6.  Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

7.  Renal oxidative stress following CO2 pneumoperitoneum-like conditions.

Authors:  Wisam Khoury; Letizia Schreiber; Amir Szold; Joseph M Klausner; Avi A Wienbroum
Journal:  Surg Endosc       Date:  2008-07-16       Impact factor: 4.584

8.  Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.

Authors:  Omer Yiginer; Fatih Ozcelik; Tugrul Inanc; Mustafa Aparci; Namik Ozmen; Bekir Yilmaz Cingozbay; Ejder Kardesoglu; Selami Suleymanoglu; Goksel Sener; Bekir Sitki Cebeci
Journal:  Clin Res Cardiol       Date:  2007-12-28       Impact factor: 5.460

9.  Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.

Authors:  Brooks M Hybertson; Kevin G Connelly; Raquel T Buser; John E Repine
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

10.  Aortic aneurysms, inflammatory pathways and nitric oxide.

Authors:  R D Sayers
Journal:  Ann R Coll Surg Engl       Date:  2002-07       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.